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ABSTRACT
Purpose: Digital mammography (DM) has replaced screen-film mammography (SFM). 
However, findings of comparisons between the performance indicators of DM and SFM for 
breast-cancer screening have been inconsistent. Moreover, the summarized results from 
studies comparing the performance of screening mammography according to device type 
vary over time. Therefore, this study aimed to compare the performance of DM and SFM 
using recently published data.
Methods: The MEDLINE, Embase, and Cochrane Library databases were searched for paired 
studies, cohorts, and randomized controlled trials published through 2018 that compared the 
performance of DM and SFM. All studies comparing the diagnostic accuracy of DM and SFM 
in asymptomatic, average-risk women aged 40 years and older were included. Two reviewers 
independently assessed the study quality and extracted the data.
Results: Thirteen studies were included in the meta-analysis. The pooled sensitivity (DM, 
0.76 [95% confidence interval {CI}, 0.70–0.81]; SFM, 0.76 [95% CI, 0.70–0.81]), specificity 
(DM, 0.96 [95% CI, 0.94–0.97]; SFM, 0.97 [95% CI, 0.94–0.98]), and area under the 
receiver-operating characteristic curve (DM, 0.94 [95% CI, 0.92–0.96]; SFM, 0.92 [95% 
CI, 0.89–0.94]) were similar for both DM and SFM. The pooled screening performance 
indicators reinforced superior accuracy of full-field DM, which is a more advanced type 
of mammography, than SFM. The advantage of DM appeared greater among women aged 
50 years or older. There was high heterogeneity among studies in the pooled sensitivity, 
specificity, and overall diagnostic accuracy estimates. Stratifying by study design (prospective 
or retrospective) and removing studies with a 2-year or greater follow-up period resulted in 
homogeneous overall diagnostic accuracy estimates.
Conclusion: The breast-cancer screening performance of DM is similar to that of SFM. The 
diagnostic performance of DM depends on the study design, and, in terms of performance, 
full-field DM is superior to SFM, unlike computed radiography systems.
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INTRODUCTION
In many Western breast-cancer (BC) screening programs, digital mammography (DM) has 
replaced screen-film mammography (SFM) [1-3]; however, many SFM systems are still used 
globally. This transition was inevitable because DM has better accuracy than SFM [2] and 
because of the shortage of SFM supplies and film archives and the low costs associated with 
DM [4]. Many studies have also shown that detection rates are higher with DM than with SFM 
[1,5-8] and that DM reduces the number of repeated tests owing to technical errors; however, 
other studies found no significant differences [9,10].
To date, several studies have narratively or systematically reviewed and compared the BC 
screening performance of DM and SFM [1,2,8,11,12]. Some quantitative reviews of these 
studies revealed that DM and SFM had statistically similar diagnostic performances for the 
overall screening population and that DM was significantly better for women aged < 50 years 
old or who had mammographically dense breasts [11,12]. However, studies comparing the 
mammographic screening test performance pose unique design challenges, as they require 
distinct criteria to appropriately assess study quality and potential bias. Because of these 
challenges, the summarized results of these studies are subject to change over time owing to 
the publication of more recent data as well as improvements in technology.
Therefore, the objective of this systematic review and meta-analysis was to compare the 
diagnostic performance of DM and SFM in terms of test accuracy. Moreover, we aimed 
to assess and compare the accuracy of DM and SFM for BC screening by using recently 
published data.
METHODS
This systematic review was conducted according to the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) guidelines [13].
Search strategy and study selection
We searched the MEDLINE, Embase, and Cochrane Library databases for articles 
published in English up to December 31, 2018. The search strategies were developed using 
combinations of free-text keywords and medical subject headings (MeSH), and we used 
similar search syntax across the other databases (Supplementary Table 1).
Two reviewers, who screened the titles and abstracts, evaluated every search hit for eligibility, 
and all potentially relevant articles were independently reviewed in full. In the case of a 
discrepancy in study selection, a consensus was reached through discussion. If no agreement 
could be reached, a third reviewer was consulted.
Studies were included if all of the following inclusion criteria were met: 1) paired studies, 
cohort studies, or randomized controlled trials (RCTs) comparing SFM and DM; 2) 
asymptomatic women aged 40 years or older who were enrolled in BC screening programs or 
for whom mammography was recommended; and 3) availability of sufficient data to construct 
2 × 2 contingency tables for each mammography method. Studies were excluded if they 
assessed populations that are at a high risk of breast and/or ovarian cancer. Disagreements 
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between the two reviewers were resolved through a consensus meeting with a third reviewer.  
If needed, we contacted the authors of the published studies for additional information.
Quality assessment and data extraction
Two separate observers independently evaluated the risk of bias of the included studies, 
using the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2) instrument 
[14]. Disagreements were resolved via a joint review of the manuscript to reach consensus. 
When multiple articles for a single study were found, we used data from the most recent 
publication. Each item was scored as “yes,” “no,” or “unclear” if insufficient information was 
available to make an accurate judgment. Disagreements were resolved by the third reviewer. 
We used RevMan 5.3 software (The Cochrane Collaboration, Copenhagen, Denmark) to 
graphically display the quality assessment results.
To perform accuracy analyses, we extracted the relevant data from each study, including the 
first author's name, publication year, study location, sample size, description of the study 
population (age), study design (prospective, retrospective, or unknown), and consideration 
of the learning-curve effect. For each study, the values for true positive, false positive, false 
negative, true negative, sensitivity, and specificity results for the detection of BC were extracted.
Statistical analysis
We estimated the sensitivity and specificity, with 95% confidence intervals (CIs), of each 
selected study. The overall pooled sensitivity, specificity, positive likelihood (LR+), negative 
likelihood (LR−), diagnostic odds ratio (DOR), and area under the summary receiver-operating 
characteristic (SROC) curve (AUC) of DM and SFM were calculated using a bivariate 
random-effects model [15]. We also generated a hierarchical summary receiver-operating 
characteristic (HSROC) curve that plotted the individual and summary estimates of 
sensitivities and specificities, along with 95% CI and prediction region, and calculated the 
area under the HSROC curve [16].
Heterogeneity was assessed using the Cochran Q test and Higgins I2 heterogeneity index. We 
applied the random-effects model by using recently introduced bivariate mixed effects for 
diagnostic meta-analysis [17]. Several factors that could affect the diagnostic accuracy and 
cause heterogeneity were incorporated in the bivariate model to explore their influence on 
sensitivity and specificity. The following factors were evaluated: type of DM system (only  
full-field digital mammography [FFDM] or all DM, including computed radiography 
systems), enrollment of women younger than 50 years of age (yes or no), consideration of 
the learning-curve effect, initial year the digital mammogram was acquired, study design 
(prospective or retrospective), and study location (European countries or North America). 
We performed subgroup analyses to identify factors that influenced the diagnostic accuracy 
if four or more studies were included. To determine whether studies with short follow-up 
periods or negative mammography results were causing heterogeneity in the summary 
estimates, we performed sensitivity analyses by removing studies with a 1-year follow-up 
period and by estimating the I2 statistic for the remaining group. Furthermore, to ensure 
that no single study influenced the overall results, we conducted “leave-one-out” sensitivity 
analyses by repeating the analyses with the following exclusion of each study. Finally, we 
performed meta-regression analyses based on linear regression models for assessing the 
influence of the heterogeneity of study populations on the meta-analysis results. We performed 
regression analyses when heterogeneity was significant and when a reasonable number of data 
points were available (≥ 4).
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The statistical computations were performed using STATA 14.0 software (STATA Corp., 
College, USA) for all statistical analyses. We considered 2-sided p-values < 0.05 to be 
statistically significant.
Publication bias
Publication bias was assessed visually by using funnel plots.
RESULTS
Search strategy and study selection
Figure 1 is a flowchart illustrating study selection. Our initial search yielded 7,774 entries. 
After screening the titles and abstracts, we identified 53 articles for full-text review; of these, 
13 items met all the inclusion criteria and were included in our analysis [10,18-29].
Characteristics of the included studies
The main characteristics of the included studies are shown in Table 1. All included studies 
were published between 2002 and 2018. Thirteen articles described one RCT [21], three 
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Full-text articles excluded, with reasons (n = 40)
Article unavailable (n = 1)
Absence of conditions of interest (n = 12)
Duplicated data (n = 5)
Non-eligible index test (n = 1)
Non-eligible reference test (n = 8)
Untargeted population (n = 4)
Partial verification (n = 9)
·
·
·
·
·
·
·
Studies included in quantitative synthesis
(meta-analysis)
(n = 13)
Studies included in qualitative synthesis
(n = 13)
Full-text articles assessed for eligibility
(n = 53)
Records screened
(n = 3,182)
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(n = 3,129)
Records after duplicates removed
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through database searching
(n = 7,771)
Additional records identified
through hand-search
(n = 3)
Figure 1. Flowchart for the process of study inclusion in the review.
paired studies (in which the participants underwent both types of mammography) [18-20], 
and nine cohort studies [10,22-29] of screening mammography sensitivity and specificity for 
BC in average-risk asymptomatic women; the sample sizes ranged from 7,366 to 7,343,327. 
Six studies enrolled women aged < 50 years old [18,19,21,22,25,28]; 8 studies were conducted 
in European countries [10,20,21,23-25,27,29], and 5 were conducted in North America 
[18,19,22,26,28].
Four studies collected digital mammograms from the year 2004 [23,25-27], while the initial 
year of digital mammogram enrollment in the other 9 studies was after 2004 [10,18-22,24,28, 
29]. Nine of the 13 studies used the Breast Imaging Reporting and Data System (BI-RADS) 
for mammogram interpretation [10,18,19,22-24,27-29]. Four studies used screening 
mammograms with longitudinal follow-up of women with negative mammography results 
through cancer registries, medical records, or national insurance claims approximately 1 year 
later, as the reference standard [19,22,25,28]; 9 studies performed a follow-up for 2 years or 
more for negative screening results [10,18,20,21,23,24,26,27,29] (Table 2).
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Table 1. Main characteristics of the population screened
Study Year of 
publication
Study location Study design Age range (yr) No. of screening 
mammograms
Lewin et al. [18] 2002 United States Paired study ≥ 40 13,472
Pisano et al. [19] 2005 United States Paired study ≥ 40 85,520
Skaane et al. [20] 2005 Norway Paired study 50–69 7,366
Skaane et al. [21] 2007 Norway Randomized clinical trial 45–69 23,929
Kerlikowske et al. [22] 2011 United States Prospective cohort study 40–79 869,286
Nederend et al. [23] 2014 The Netherlands Prospective cohort study 50–75 123,952
Sala et al. [24] 2015 Spain Retrospective cohort study 50–69 161,992
Campari et al. [25] 2016 Italy Retrospective cohort study 45–79 87,436
de Munck et al. [10] 2016 The Netherlands Retrospective cohort study 50–75 576,069
Prummel et al. [26] 2016 Canada Retrospective cohort study 50–75 742,092
Weber et al. [27] 2016 The Netherlands Retrospective cohort study 50–75 417,746
Dabbous et al. [28] 2017 United States Retrospective cohort study 40–79 710,749
Sankatsing et al. [29] 2018 The Netherlands Retrospective cohort study 50–74 7,343,327
Table 2. Main characteristics of the mammography examination
Study Year Features of mammography examination
Year of film 
mammogram*
Year of digital 
mammogram*
Diagnostic 
scale
Reference 
standard
No. of 
views
Single vs. double 
interpretation
Consideration of 
learning-curve effect
% of cases 
with DCIS
Lewin et al. [18] 2002 1999–1999 1999–1999 BI-RADS 2-year follow-up 2 S N/A N/A
Pisano et al. [19] 2005 2001–2003 2001–2003 BI-RADS/scale 1–7 1-year follow-up N/A S N/A 23.3
Skaane et al. [20] 2005 2000–2001 2000–2001 Scale 1–5 2-year follow-up 2 D No 31.6
Skaane et al. [21] 2007 2000–2001 2000–2001 Scale 1–5 2-year follow-up 2 D Yes N/A
Kerlikowske et al. [22] 2011 2000–2006 2000–2006 BI-RADS 1-year follow-up 1–2 N/A N/A 24.2
Nederend et al. [23] 2014 2008–2010 2009–2011 BI-RADS 2-year follow-up 1 D N/A 19.9
Sala et al. [24] 2015 1995–2007 2004–2010 BI-RADS 30-month follow-up 2 D Yes 16.8
Campari et al. [25] 2016 2011 2012 N/A 1-year follow-up N/A D Yes 16.8
de Munck et al. [10] 2016 2004–2009 2004–2010 BI-RADS 2-year follow-up 2 D No 14.9
Prummel et al. [26] 2016 2008–2009 2008–2009 N/A 2-year follow-up 2 S Yes 17.2
Weber et al. [27] 2016 2000–2010 2009–2011 BI-RADS 2-year follow-up 2 D No 18.6
Dabbous et al. [28] 2017 2001–2010 2001–2010 BI-RADS 1-year follow-up 2 N/A No N/A
Sankatsing et al. [29] 2018 2004–2010 2004–2011 BI-RADS 2-year follow-up 2 D No N/A
BI-RADS = Breast Imaging Reporting and Data System; D = double interpretation for each mammogram; DCIS = ductal carcinoma in-situ; N/A = not available;  
S = single interpretation for each mammogram; S/D = a combination of single and double interpretation.
*Reported year in which the mammograms were obtained.
Quality assessment
The QUADAS-2 instrument suggested that the highest risk of bias occurred in the “flow and 
timing” category (Supplementary Figure 1), which is likely attributed to a study that acquired 
BC screening data from a single health care delivery organization, using a cancer registry as 
the reference standard [28]. This study only reported the final number of patients included in 
the data analysis, and the flow of study population selection was not adequately described in 
the article.
Overall diagnostic accuracy
The overall pooled sensitivity, specificity, AUC, LR+, LR−, and DOR of BC screening 
conducted using the DM systems were 0.76 (95% CI, 0.70–0.81), 0.96 (95% CI, 0.94–0.97), 
0.94 (95% CI, 0.92–0.96), 18.0 (95% CI, 12.2–26.7), 0.25 (95% CI, 0.20–0.32), and 72 (95% 
CI, 44–118), respectively. The overall pooled sensitivity, specificity, AUC, LR+, LR−, and DOR 
for the SFM systems were 0.76 (95% CI 0.70–0.81), 0.97 (95% CI, 0.94–0.98), 0.92 (95% CI, 
0.89–0.94), 22.5 (95% CI, 13.1–38.8), 0.25 (95% CI, 0.20–0.31), and 91 (95% CI, 52–157), 
respectively (Table 3, Supplementary Figure 2, and Supplementary Table 2).
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Table 3. Subgroup analysis based on the type of digital mammography system, enrollment of women < 50 years of age, consideration of learning-curve effect, 
the initial year of obtaining digital mammograms, study design, and study location
Subgroup No. of 
studies
Sensitivity (95% CI) Specificity (95% CI) AUC (95% CI)
SFM I2* DM I2* SFM I2* DM I2* SFM I2* DM I2*
Overall 13 0.76 
(0.70–0.81)
99.8 0.76 
(0.70–0.81)
99.3 0.97 
(0.94–0.98)
100.0 0.96 
(0.94–0.97)
100.0 0.92 
(0.89–0.94)
100.0 0.94 
(0.92–0.96)
100.0
Type of digital mammography system
Only FFDM 9 0.75 
(0.69–0.80)
97.9 0.74 
(0.66–0.81)
97.4 0.97 
(0.94–0.98)
100.0 0.96 
(0.93–0.97)
100.0 0.90 
(0.87–0.92)
100.0 0.94 
(0.91–0.95)
100.0
All DM† 4 0.80 
(0.68–0.88)
100.0 0.80 
(0.71–0.87)
99.9 0.96 
(0.91–0.98)
100.0 0.95 
(0.91–0.98)
100.0 0.95 
(0.92–0.96)
100.0 0.95 
(0.92–0.96)
100.0
Enrollment of women younger than 50 years
Yes 6 0.79 
(0.68–0.87)
98.6 0.79 
(0.67–0.87)
97.4 0.93 
(0.88–0.96)
100.0 0.93 
(0.90–0.95)
100.0 0.94 
(0.91–0.95)
99.0 0.94 
(0.92–0.96)
99.0
No 7 0.74 
(0.71–0.77)
99.7 0.75 
(0.69–0.79)
99.4 0.98 
(0.97–0.99)
100.0 0.97 
(0.96–0.98)
100.0 0.87 
(0.84–0.90)
100.0 0.92 
(0.90–0.94)
100.0
Consideration of learning-curve effect
Yes 4 0.79 
(0.67–0.87)
98.7 0.80 
(0.70–0.87)
96.1 0.96 
(0.94–0.98)
100.0 0.96 
(0.94–0.97)
99.9 0.97 
(0.95–0.98)
98.0 0.97 
(0.95–0.98)
97.0
No 5 0.77 
(0.69–0.83)
99.8 0.75 
(0.63–0.84)
99.7 0.98 
(0.95–0.99)
100.0 0.97 
(0.94–0.99)
100.0 0.93 
(0.90–0.95)
100.0 0.95 
(0.93–0.97)
100.0
Initial year of obtaining digital mammograms
Before 2004 9 0.74 
(0.67–0.80)
99.9 0.72 
(0.64–0.79)
99.7 0.96 
(0.92–0.98)
100.0 0.95 
(0.92–0.97)
100.0 0.90 
(0.87–0.92)
100.0 0.92 
(0.89–0.94)
100.0
From 2004 4 0.80 
(0.71–0.87)
99.3 0.83 
(0.76–0.87)
95.0 0.98 
(0.95–0.99)
100.0 0.96 
(0.94–0.98)
100.0 0.96 
(0.94–0.97)
100.0 0.96 
(0.94–0.98)
99.0
Study design
Prospective 
studies
6 0.71 
(0.63–0.78)
96.5 0.69 
(0.59–0.78)
96.8 0.95 
(0.91–0.98)
100.0 0.94 
(0.91–0.96)
100.0 0.87 
(0.84–0.90)
100.0 0.92 
(0.89–0.94)
99.0
Retrospective 
studies
7 0.79 
(0.72–0.85)
99.9 0.80 
(0.74–0.86)
99.6 0.97 
(0.94–0.99)
100.0 0.97 
(0.94–0.98)
100.0 0.94 
(0.91–0.95)
100.0 0.95 
(0.93–0.97)
100.0
Study location
European 
countries
8 0.74 
(0.67–0.80)
99.6 0.75 
(0.67–0.82)
99.4 0.98 
(0.97–0.99)
100.0 0.97 
(0.97–0.98)
99.9 0.96 
(0.94–0.97)
100.0 0.97 
(0.95–0.99)
99.0
North America 5 0.79 
(0.70–0.86)
96.7 0.77 
(0.67–0.86)
96.2 0.90 
(0.87–0.92)
100.0 0.91 
(0.89–0.92)
99.8 0.93 
(0.90–0.95)
100.0 0.93 
(0.90–0.95)
99.0
CI = confidence interval; AUC = area under the curve; SFM = screen-film mammography; DM = digital mammography; FFDM = full-field digital mammography.
*Inconsistency index; †All DM systems including the computed radiography system.
Heterogeneity exploration
As shown in Table 3 and Figure 2, we identified substantial heterogeneity between studies 
when calculating the pooled sensitivity (DM, I2 = 99.3%; SFM, I2 = 99.8%), specificity (DM, 
I2 = 100.0%; SFM, I2 = 100.0%), and AUC (DM, I2 = 100.0%; SFM, I2 = 100.0%) of screening 
mammograms for BC in each mammography system by using the bivariate model.
Excluding the studies with 1-year follow-up periods did not reduce the heterogeneity for 
overall sensitivity (DM, I2 = 99.6%; SFM, I2 = 99.8%), specificity (DM, I2 = 100.0%; SFM,  
I2 = 100.0%), or AUC (DM, I2 = 100.0%; SFM, I2 = 100.0%). However, removing studies with 
1-year follow-up periods decreased the pooled AUCs of DM and SFM (DM, 0.92 [95% CI, 
0.89–0.94; SFM, 0.84 [95% CI, 0.81–0.87]).
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Study Sensitivity (95% CI) Specificity (95% CI)
Sankatsing et al. [29] 0.71 (0.70–0.71) 0.99 (0.99–0.99)
Dabbous et al. [28] 0.88 (0.87–0.90) 0.87 (0.87–0.87)
de Munck et al. [10] 0.69 (0.68–0.71) 0.99 (0.99–0.99)
Weber et al. [27] 0.72 (0.70–0.74) 0.99 (0.99–0.99)
Prummel et al. [26] 0.80 (0.79–0.82) 0.93 (0.93–0.93)
Campari et al. [25] 0.91 (0.87–0.94) 0.97 (0.97–0.97)
Sala et al. [24] 0.75 (0.71–0.79) 0.95 (0.95–0.95)
Nederend et al. [23] 0.74 (0.69–0.78) 0.99 (0.99–0.99)
Kerlikowske et al. [22] 0.84 (0.81–0.86) 0.90 (0.90–0.90)
Skaane et al. [21] 0.62 (0.51–0.71) 0.98 (0.98–0.98)
Skaane et al. [20] 0.64 (0.47–0.79) 0.97 (0.97–0.98)
Pisano et al. [19] 0.66 (0.60–0.72) 0.92 (0.92–0.92)
Lewin et al. [18] 0.66 (0.51–0.79) 0.86 (0.85–0.86)
Combined 0.76 (0.70–0.81) 0.97 (0.94–0.98)
Q = 6,987.88, df = 12.00, p = 0.00 Q = 2.7e+05, df = 12.00, p = 0.00
I2 = 99.83 (99.81–99.85) I2 = 100.00 (100.00–100.00)
0.5
Sensitivity
0.9 0.8
Specificity
1.0
A    Screen-film mammography
Study Sensitivity (95% CI) Specificity (95% CI)
Sankatsing et al. [29] 0.74 (0.73–0.75) 0.99 (0.98–0.99)
Dabbous et al. [28] 0.89 (0.87–0.91) 0.89 (0.89–0.89)
de Munck et al. [10] 0.67 (0.62–0.72) 0.99 (0.99–0.99)
Weber et al. [27] 0.81 (0.78–0.83) 0.98 (0.98–0.98)
Prummel et al. [26] 0.80 (0.78–0.82) 0.93 (0.93–0.93)
Campari et al. [25] 0.91 (0.87–0.94) 0.96 (0.96–0.96)
Sala et al. [24] 0.75 (0.71–0.79) 0.97 (0.96–0.97)
Nederend et al. [23] 0.77 (0.74–0.81) 0.98 (0.97–0.98)
Kerlikowske et al. [22] 0.82 (0.80–0.83) 0.91 (0.91–0.91)
Skaane et al. [21] 0.68 (0.55–0.80) 0.96 (0.96–0.97)
Skaane et al. [20] 0.49 (0.32–0.65) 0.96 (0.95–0.97)
Pisano et al. [19] 0.70 (0.64–0.76) 0.92 (0.92–0.92)
Lewin et al. [18] 0.54 (0.39–0.68) 0.89 (0.88–0.89)
Combined 0.76 (0.70–0.81) 0.96 (0.94–0.97)
Q = 1,757.33, df = 12.00, p = 0.00 Q = 1.2e+05, df = 12.00, p = 0.00
I2 = 99.32 (99.18–99.44) I2 = 99.99 (99.99–99.99)
B    Digital mammography
0.3
Sensitivity
0.9 0.9
Specificity
1.0
Figure 2. Forest plot presenting the estimates of sensitivity and specificity of each study across two screening mammography systems. The estimates of each 
study are plotted. Error bars = calculated 95% confidence intervals; FN = false negative; FP = false positive; TN = true negative; TP = true positive.
Leave-one-out sensitivity analyses
To evaluate the robustness of the summarized diagnostic accuracy results, we performed a 
leave-one-out sensitivity analysis by iteratively removing one study at a time and recalculating 
the summary sensitivities and specificities (Supplementary Figure 3). Leave-one-out analyses 
showed no marked difference in results, indicating that no single study had any impact on them.
Subgroup analysis
Type of DM system
There were considerable differences in the AUC estimates of SROC according to the 
mammography system in our only FFDM subgroup. Studies using only FFDM as an index test 
had lower AUCs for DM and SFM than did studies using all DM as an index test (Table 3). 
We observed high heterogeneity in all pooled test accuracy indicators, regardless of the DM 
type. When we excluded studies with 1-year follow-up periods in our only FFDM subgroup, 
the pooled sensitivity and specificity estimates and their associated heterogeneity remained 
unchanged (Table 4). However, the AUC estimates of the SROCs decreased, showing 
significant differences between DM and SFM with no change in heterogeneity. Because of the 
scarcity of studies, we could not perform a sensitivity analysis in all the DM subgroups.
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Table 4. Summary estimates of subgroups after removing studies with a 1-year follow-up period
Subgroup No. of 
studies
Sensitivity (95% CI) Specificity (95% CI) AUC (95% CI)
SFM I2* DM I2* SFM I2* DM I2* SFM I2* DM I2*
Overall 9 0.73 
(0.69–0.77)
99.8 0.72 
(0.65–0.77)
99.6 0.98 
(0.95–0.99)
100.0 0.97 
(0.95–0.98)
100.0 0.84 
(0.81–0.87)
100.0 0.92 
(0.89–0.94)
100.0
Type of digital mammography system
Only FFDM 8 0.73 
(0.69–0.77)
97.2 0.71 
(0.64–0.78)
91.8 0.97 
(0.95–0.99)
100.0 0.96 
(0.94–0.98)
99.9 0.84 (0.81–
0.87)
100.0 0.92 
(0.90–0.94)
100.0
All DM†,‡ 4 0.80 
(0.68–0.88)
100.0 0.80 
(0.71–0.87)
99.9 0.96 
(0.91–0.98)
100.0 0.95 
(0.91–0.98)
100.0 0.95 
(0.92–0.96)
100.0 0.95 
(0.92–0.96)
100.0
Enrollment of women younger than 50 years
Yes† 5 0.81 
(0.70–0.89)
98.5 0.80 
(0.67–0.89)
97.6 0.93 
(0.87–0.97)
100.0 0.93 
(0.89–0.96)
100.0 0.94 
(0.92–0.96)
99.0 0.95 
(0.93–0.96)
98.0
No 7 0.74 
(0.71–0.77)
99.7 0.75 
(0.69–0.79)
99.4 0.98 
(0.97–0.99)
100.0 0.97 
(0.96–0.98)
100.0 0.87 
(0.84–0.90)
100.0 0.92 
(0.90–0.94)
100.0
Consideration of learning-curve effect
Yes† 4 0.79 
(0.67–0.87)
98.7 0.80 
(0.70–0.87)
96.1 0.96 
(0.94–0.98)
100.0 0.96 
(0.94–0.97)
99.9 0.97 
(0.95–0.98)
98.0 0.97 
(0.95–0.98)
97.0
No 4 0.71 
(0.70–0.72)
98.1 0.70 
(0.58–0.79)
99.3 0.99 
(0.98–0.99)
99.8 0.98 
(0.97–0.99)
99.9 0.79 
(0.76–0.83)
99.0 0.96 
(0.94–0.98)
99.0
Initial year of obtaining digital mammograms
Before 2004 6 0.72 
(0.70–0.75)
99.9 0.67 
(0.59–0.74)
99.8 0.97 
(0.94–0.99)
100.0 0.97 
(0.94–0.98)
100.0 0.78 
(0.74–0.82)
100.0 0.88 
(0.85–0.90)
98.0
From 2004† 4 0.80 
(0.71–0.87)
99.3 0.83 
(0.76–0.87)
95.0 0.98 
(0.95–0.99)
100.0 0.96 
(0.94–0.98)
100.0 0.96 
(0.94–0.97)
100.0 0.96 
(0.94–0.98)
99.0
Study design
Prospective 
studies
4 0.68 
(0.61–0.74)
94.6 0.66 
(0.54–0.76)
94.2 0.97 
(0.92–0.99)
99.9 0.95 
(0.92–0.97)
99.8 0.80 
(0.76–0.83)
96.0 0.91 
(0.88–0.93)
0.0
Retrospective 
studies
5 0.74 
(0.70–0.77)
99.8 0.76 
(0.72–0.80)
99.4 0.98 
(0.96–0.99)
100.0 0.98 
(0.96–0.99)
100.0 0.87 
(0.84–0.90)
100.0 0.90 
(0.87–0.93)
100.0
Study location
European 
countries
7 0.72 
(0.70–0.73)
99.6 0.72 
(0.66–0.78)
99.4 0.98 
(0.98–0.99)
100.0 0.98 
(0.97–0.98)
99.9 0.79 
(0.76–0.83)
100.0 0.95 
(0.93–0.97)
99.0
Non-European 
countries†
5 0.79 
(0.70–0.86)
96.7 0.77 
(0.67–0.86)
96.2 0.90 
(0.87–0.92)
100.0 0.91 
(0.89–0.92)
99.8 0.93 
(0.90–0.95)
100.0 0.93 
(0.90–0.95)
99.0
Variance of paired design study was adjusted by correlation.
CI = confidence interval; AUC = area under the curve; SFM = screen-film mammography; DM = digital mammography; FFDM = full-field digital mammography.
*Inconsistency index; †Unable to perform a sensitivity analysis due to the lack of data/studies; ‡All digital mammography systems including the computed 
radiography system.
Enrollment of women younger than 50 years old
The difference in AUC estimates according to the mammography system (DM vs. SFM) 
significantly varied depending on the inclusion of women aged < 50 years old. Studies that 
enrolled women aged < 50 years old had a higher specificity than did studies that enrolled 
only women aged ≥ 50 years old; however, no significant difference was observed between DM 
versus SFM (Table 3). Studies that recruited women aged < 50 years old had similar AUCs for 
DM and SFM, while studies that enrolled women aged ≥ 50 years old had higher AUCs for DM 
than for SFM. Sensitivities remained similar for both DM and SFM regardless of the subgroups. 
We saw high heterogeneity in all pooled diagnostic accuracy indicators; even after removing 
studies with 1-year follow-up periods, all the indicators were highly heterogeneous (Table 4).
Consideration of the learning-curve effect
Consideration of the learning-curve effect did not influence the performance characteristics 
for DM compared to that of SFM. In both subgroups, no significant difference was observed 
in the sensitivity and specificity estimates between DM and SFM. High heterogeneity was 
shown in both subsets and eliminating studies with 1-year follow-up periods did not affect 
the heterogeneity of summary diagnostic indicators. However, after excluding studies with 
1-year follow-up periods, the AUC of SFM decreased in studies without consideration of 
the learning-curve effect and became significantly lower than the AUC of DM in the same 
subgroup (Table 4).
The initial year of obtaining digital mammograms
Whether the digital mammograms were collected before or after the year 2004 had no impact 
on the diagnostic accuracy of DM and SFM. All the test accuracy indicators of DM were 
similar to those of SFM and were highly heterogeneous in both subgroups. After removing 
studies with 1-year follow-up periods, the AUC of DM and SFM decreased in the subgroup of 
digital mammograms obtained until 2004, but the heterogeneity remained high.
Study design
Estimates of sensitivity, specificity, and AUC of the SROC for DM were similar to those for 
SFM and highly heterogeneous in both subgroups according to the study design. When 
we excluded studies with 1-year follow-up periods, the pooled sensitivity and specificity 
estimates of DM were similar to those of SFM in both study designs. After removing studies 
with 1-year follow-up periods, the AUCs of DM and SFM decreased in prospective studies, 
and the pooled AUC for DM was highly homogeneous (Table 4). In retrospective studies, the 
pooled AUCs decreased, but the heterogeneity remained high.
Study location
Subgroup analysis according to study location showed no difference between the pooled 
test performance characteristics of DM compared to those of SFM by subgroups. In both 
subgroups, heterogeneity between studies was high for sensitivity, specificity, and AUC 
(Table 3). The exclusion of studies with 1-year follow-up periods lowered the pooled AUC 
estimates of studies from European countries. However, sensitivity and specificity estimates 
remained similar in studies performed in European countries despite the removal of studies 
with 1-year follow-up periods with high heterogeneity (Table 4).
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Meta-regression analyses
There was high heterogeneity among studies in both subgroups on the SFM basis and the DM 
basis. To assess the influence of the heterogeneity of the study population and the data on 
meta-analysis results, we conducted meta-regression analyses.
Meta-regression analyses showed that the following factors led to a high heterogeneity in the 
sensitivity and specificity of the SFM screening results (Supplementary Figure 4A and B): 
enrollment of women younger than 50 years, study design, and study location. However, 
when we performed subgroup analyses in these subgroups, the pooled estimates remained 
highly heterogeneous (Table 3). In the DM screening results, on the other hand, the following 
factors were found to be related to the high heterogeneity (Supplementary Figure 4C and D): 
type of DM system, study design, and study location. According to the subgroup analysis 
results, however, the heterogeneity remained high except to the area under the summary 
receiver-operating characteristic curve of the prospective design group (Table 3).
Publication bias
We conducted the publication bias analysis for the included studies. However, as shown in 
Supplementary Figure 5, the funnel plots were asymmetric, and the p-value of Deeks' test was 
0.08 for DM and 0.06 for SFM, indicating that a publication bias existed in the meta-analysis 
for both mammography systems.
DISCUSSION
Our study findings suggest that the pooled sensitivities of DM and SFM were approximately 
76% and 76%, respectively, whereas those of DM and SFM were approximately 96% and 97%, 
respectively. Hence, the overall accuracy of DM and SFM was 94% and 92%, respectively. For 
all diagnostic performance measures, we saw high heterogeneity among studies. To convey 
this issue, we performed a subgroup analysis to identify potential sources of heterogeneity 
between studies.
We assumed that the heterogeneity in test accuracy might be caused by the type of DM 
system used as an index test in each study. The subgroup analysis showed that the type of 
DM system significantly affected the pooled AUC of SROC; in our only FFDM subgroup, DM 
was more accurate than was SFM. In addition, the AUC of DM was similar to that of SFM in 
the all DM subgroup. Nine studies to date have compared the accuracy of FFDM and SFM in 
asymptomatic women with an average risk of BC.
We also investigated whether the enrollment of women aged < 50 years old had any impact 
on the test accuracy of screening mammography. Surprisingly, the pooled AUC of the 
SROC was higher for DM than for SFM in studies with participants aged ≥ 50 years old only; 
meanwhile, the pooled AUC of DM was lower than that of SFM in the studies on women 
aged < 50 years old. However, heterogeneity in the pooled estimates of AUC remained high 
despite stratification by patient age and the exclusion of studies with 1-year follow-up periods. 
Previous studies have indicated that FFDM yields better screening performance than does 
SFM, especially in younger women; these studies, however, included only three studies in the 
meta-analysis [11,12].
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According to the subgroup analyses of studies with 2-year and longer follow-up periods, 
consideration of the learning-curve effect could have effects on the heterogeneity of the AUCs 
of SFM systems. The pooled AUC for SFM in the studies that did not consider the learning-
curve effect was 79%, while the pooled AUC for DM was 99%. However, for studies that 
considered the learning-curve effect, the pooled AUCs were 97% for SFM and 97% for FFDM, 
suggesting that consideration of the learning-curve effect might have influenced the better 
test performance of DM systems over SFM systems in a previous meta-analysis study [12].
The results of the subgroup analyses according to the initial year of obtaining digital 
mammograms showed that studies with recently collected digital mammograms had better 
test performance for both DM and SFM than did studies with older data for DM, even though 
the pooled AUCs of DM and SFM were not significantly different. This result indicates that 
the test accuracy of mammographic screening has changed over time. However, studies that 
collected BC screening data prospectively showed higher test accuracy in DM than in SFM. 
Moreover, after removing studies with 1-year follow-up periods, the AUCs of both DM and 
SFM of prospective studies decreased, whereas the pooled AUC of DM was homogenous 
(I2 = 0%). The subgroup analysis considering study location did not explain the issue of 
heterogeneity, even though the pooled AUCs of European studies were higher than those of 
North American studies.
Our study had several limitations. First, heterogeneity existed in most analyses. Nevertheless, 
the less heterogeneous subgroup summary estimates were generally similar to the overall 
summary estimates, suggesting that despite statistical heterogeneity, the overall summary 
measures are reasonable estimations of overall test accuracy for DM than for SFM. Second, 
we could not determine the sensitivity and specificity of DM and SFM for breast adenomas 
stratified by pathological diagnosis or cancer stage owing to the complexity of accounting 
for various definitions of these subgroups used in each study. However, the meta-regression 
analysis showed that the proportion of ductal carcinoma in-situ (DCIS) out of all cancer types 
has no significant effect on the test accuracy across studies (Supplementary Figure 4). 
This finding indicates that considering cancer stage (DCIS vs. invasive) as a subgroup could 
have no impact on our meta-analysis results. Third, we could not account and adjust for 
various factors associated with the mammography interpreters. Fourth, our study lacked 
data regarding other sub-factors such as breast density, menopausal status, and the use of 
computer-aided detection. Last, our study may be subject to a publication bias.
In summary, the systematic review and meta-analysis results suggest that DM has similar 
accuracy, specificity, and sensitivity to SFM in the detection of BC. Pooled screening 
performance estimates reinforce that the accuracy of FFDM is better than that of 
conventional SFM systems; nonetheless, the performance of all DM systems, including 
computed radiography systems, is similar to that of SFM systems, suggesting that the 
digitalization of screening mammography should be transitioned to the FFDM system 
but not to the computed radiography system. Additionally, our meta-analysis shows high 
inconsistency in the summarized test accuracy indicators of screening mammography; 
hence, the results should be interpreted carefully. Although we found heterogeneity in all 
analyses, we were not able to examine several sources of heterogeneity owing to scarce 
information in the selected articles; therefore, further studies that compare the diagnostic 
accuracy of DM to that of SFM should be cautiously designed and reported.
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Supplementary Table 1
Search terms
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Supplementary Table 2
Subgroup analysis based on the type of digital mammography system, enrollment of women 
aged 40–49 years old, consideration of learning-curve effect, the initial year of obtaining 
digital mammograms, study design, and study location
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Supplementary Figure 1
Quality assessment results of the 13 included studies evaluated with the Quality Assessment 
of Diagnostic Accuracy Studies 2 (QUADAS-2) instrument.
Click here to view
Supplementary Figure 2
Sensitivity and specificity of individual studies plotted in ROC space for comparison of DM 
versus SFM. (A) shows bivariate summary estimates of sensitivity and specificity for DM and 
SFM with the 95% confidence region (dashed line) and prediction region (finely dotted line). 
(B) shows estimated SROC curves and expected operating points for DM and SFM for breast 
cancer screening by hierarchical regression modeling.
Click here to view
Supplementary Figure 3
The horizontal axis shows the excluded study. The horizontal axis represents the summary 
sensitivity and the summary specificity. Each square indicates the summary sensitivity or 
specificity when the left study is excluded in this meta-analysis. The 2 ends of every broken 
line represent the 95% CI respectively. (A) Sensitivity1 (SFM); (B) Specificity1 (SFM); (C) 
Sensitivity2 (DM); (D) Specificity2 (DM).
Click here to view
Supplementary Figure 4
The horizontal axis shows the covariates of the meta-regression analysis. The horizontal axis 
represents the sensitivity or the specificity. Each circle indicates the summary sensitivity 
or specificity for each subgroup. The two ends of every broken line represent the 95% 
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CI respectively. (A) Sensitivity1 (SFM); (B) Specificity1 (SFM); (C) Sensitivity2 (DM); (D) 
Specificity2 (DM).
Click here to view
Supplementary Figure 5
Deeks' test result of the diagnostic meta-analysis. (A) the result of the diagnostic meta-
analysis for digital mammography; (B) the result of the diagnostic meta-analysis for screen-
film mammography.
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